- Home
- MYGN vs AROW Comparison
MYGN vs AROW Comparison
Compare MYGN & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- AROW
- Stock Information
- Founded
- MYGN 1991
- AROW 1851
- Country
- MYGN United States
- AROW United States
- Employees
- MYGN N/A
- AROW N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AROW Major Banks
- Sector
- MYGN Health Care
- AROW Finance
- Exchange
- MYGN Nasdaq
- AROW Nasdaq
- Market Cap
- MYGN 423.1M
- AROW 463.8M
- IPO Year
- MYGN 1995
- AROW N/A
- Fundamental
- Price
- MYGN $6.02
- AROW $29.38
- Analyst Decision
- MYGN Hold
- AROW Hold
- Analyst Count
- MYGN 13
- AROW 1
- Target Price
- MYGN $13.50
- AROW $28.00
- AVG Volume (30 Days)
- MYGN 2.4M
- AROW 38.1K
- Earning Date
- MYGN 08-05-2025
- AROW 07-24-2025
- Dividend Yield
- MYGN N/A
- AROW 3.96%
- EPS Growth
- MYGN N/A
- AROW N/A
- EPS
- MYGN N/A
- AROW 1.83
- Revenue
- MYGN $832,900,000.00
- AROW $140,422,000.00
- Revenue This Year
- MYGN N/A
- AROW $22.74
- Revenue Next Year
- MYGN $6.64
- AROW $6.91
- P/E Ratio
- MYGN N/A
- AROW $16.02
- Revenue Growth
- MYGN 3.83
- AROW 5.15
- 52 Week Low
- MYGN $3.76
- AROW $22.72
- 52 Week High
- MYGN $29.30
- AROW $34.63
- Technical
- Relative Strength Index (RSI)
- MYGN 62.34
- AROW 66.07
- Support Level
- MYGN $5.23
- AROW $27.70
- Resistance Level
- MYGN $6.07
- AROW $29.21
- Average True Range (ATR)
- MYGN 0.39
- AROW 0.71
- MACD
- MYGN 0.05
- AROW 0.11
- Stochastic Oscillator
- MYGN 81.27
- AROW 95.17
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About AROW Arrow Financial Corporation
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.